X-154535187-C-T

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBS2_Supporting

The NM_001360016.2(G6PD):​c.466G>A​(p.Glu156Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000868 in 1,209,283 control chromosomes in the GnomAD database, including 2 homozygotes. There are 34 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., 5 hem., cov: 23)
Exomes 𝑓: 0.000081 ( 2 hom. 29 hem. )

Consequence

G6PD
NM_001360016.2 missense

Scores

1
5
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:3B:1O:1

Conservation

PhyloP100: 0.964
Variant links:
Genes affected
G6PD (HGNC:4057): (glucose-6-phosphate dehydrogenase) This gene encodes glucose-6-phosphate dehydrogenase. This protein is a cytosolic enzyme encoded by a housekeeping X-linked gene whose main function is to produce NADPH, a key electron donor in the defense against oxidizing agents and in reductive biosynthetic reactions. G6PD is remarkable for its genetic diversity. Many variants of G6PD, mostly produced from missense mutations, have been described with wide ranging levels of enzyme activity and associated clinical symptoms. G6PD deficiency may cause neonatal jaundice, acute hemolysis, or severe chronic non-spherocytic hemolytic anemia. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.060296565).
BS2
High Hemizygotes in GnomAd4 at 5 XL geneVariant has number of hemizygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
G6PDNM_001360016.2 linkuse as main transcriptc.466G>A p.Glu156Lys missense_variant 5/13 ENST00000393562.10 NP_001346945.1
G6PDNM_000402.4 linkuse as main transcriptc.556G>A p.Glu186Lys missense_variant 5/13 NP_000393.4
G6PDNM_001042351.3 linkuse as main transcriptc.466G>A p.Glu156Lys missense_variant 5/13 NP_001035810.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
G6PDENST00000393562.10 linkuse as main transcriptc.466G>A p.Glu156Lys missense_variant 5/131 NM_001360016.2 ENSP00000377192 P4P11413-1

Frequencies

GnomAD3 genomes
AF:
0.000143
AC:
16
AN:
111791
Hom.:
0
Cov.:
23
AF XY:
0.000147
AC XY:
5
AN XY:
33985
show subpopulations
Gnomad AFR
AF:
0.000390
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000188
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000189
Gnomad OTH
AF:
0.000666
GnomAD3 exomes
AF:
0.000273
AC:
50
AN:
183269
Hom.:
1
AF XY:
0.000266
AC XY:
18
AN XY:
67741
show subpopulations
Gnomad AFR exome
AF:
0.000608
Gnomad AMR exome
AF:
0.00120
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000419
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000122
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000811
AC:
89
AN:
1097438
Hom.:
2
Cov.:
31
AF XY:
0.0000799
AC XY:
29
AN XY:
363082
show subpopulations
Gnomad4 AFR exome
AF:
0.000607
Gnomad4 AMR exome
AF:
0.000966
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000444
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000119
Gnomad4 OTH exome
AF:
0.0000652
GnomAD4 genome
AF:
0.000143
AC:
16
AN:
111845
Hom.:
0
Cov.:
23
AF XY:
0.000147
AC XY:
5
AN XY:
34049
show subpopulations
Gnomad4 AFR
AF:
0.000389
Gnomad4 AMR
AF:
0.000188
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000189
Gnomad4 OTH
AF:
0.000658
Alfa
AF:
0.0000478
Hom.:
0
Bravo
AF:
0.000276
ESP6500AA
AF:
0.000522
AC:
2
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000313
AC:
38

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:3Benign:1Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Anemia, nonspherocytic hemolytic, due to G6PD deficiency Pathogenic:1Uncertain:1Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 28, 2023- -
Uncertain significance, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Likely pathogenic, criteria provided, single submittercurationDunham Lab, University of WashingtonAug 12, 2022Variant found in hemizygotes with G6PD deficiency (PP4). Decreased activity in red blood cells of hemizygotes (21-25%) (PS3). Below expected carrier frequency in gnomAD (PM2). Post_P 0.949 (odds of pathogenicity 168.4, Prior_P 0.1). -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMar 28, 2024Variant summary: G6PD c.556G>A (p.Glu186Lys) results in a conservative amino acid change located in the Glucose-6-phosphate dehydrogenase, NAD-binding domain (IPR022674) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00027 in 183269 control chromosomes in the gnomAD database, including 1 homozygote and 18 hemizygotes. This frequency is not significantly higher than estimated for a pathogenic variant in G6PD causing Glucose 6 Phosphate Dehydrogenase Deficiency (0.00027 vs 0.29), allowing no conclusion about variant significance. c.556G>A has been reported in the literature in asymptomatic individuals affected with Glucose 6 Phosphate Dehydrogenase Deficiency (e.g. Villiamy_1988, Nafa_1994, Aggarwal_2019). These reports do not provide unequivocal conclusions about association of the variant with Glucose 6 Phosphate Dehydrogenase Deficiency. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 3393536, 32680472, 7959686, 31602632). ClinVar contains an entry for this variant (Variation ID: 10364). Based on the evidence outlined above, the variant was classified as uncertain significance. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesFeb 24, 2022- -
G6PD ILESHA Other:1
other, no assertion criteria providedliterature onlyOMIMMay 24, 2017- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Benign
-0.036
T
BayesDel_noAF
Uncertain
0.12
CADD
Benign
16
DANN
Benign
0.67
DEOGEN2
Uncertain
0.70
D;D;D;.;D;.;D
FATHMM_MKL
Benign
0.027
N
LIST_S2
Uncertain
0.97
.;.;D;D;D;D;D
M_CAP
Pathogenic
0.51
D
MetaRNN
Benign
0.060
T;T;T;T;T;T;T
MetaSVM
Uncertain
0.27
D
MutationAssessor
Benign
0.49
N;N;N;N;.;.;.
MutationTaster
Benign
1.0
N;N;N;N
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-0.88
.;.;N;N;N;N;N
REVEL
Uncertain
0.55
Sift
Benign
1.0
.;.;T;T;T;T;T
Sift4G
Benign
1.0
T;.;T;T;.;.;.
Polyphen
0.0050
B;B;B;.;.;.;.
Vest4
0.20
MVP
0.99
MPC
0.20
ClinPred
0.0018
T
GERP RS
4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.54
gMVP
0.56

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs137852313; hg19: chrX-153763402; API